Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines
Authors
Keywords
-
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-25
DOI
10.1007/s00223-021-00844-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease
- (2020) Charles Ginsberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society
- (2019) Paul Lips et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis
- (2019) N. Charoenngam et al. OSTEOPOROSIS INTERNATIONAL
- Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease
- (2018) Ashok Kumar Yadav et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions
- (2018) Robert P Heaney et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Comparative analysis of nutritional guidelines for vitamin D
- (2017) Roger Bouillon Nature Reviews Endocrinology
- High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3–4: results of a 12-week double-blind, randomized, controlled study
- (2017) Per-Anton Westerberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria
- (2017) Paweena Susantitaphong et al. BMC Nephrology
- Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials
- (2017) Connie M. Rhee et al. Journal of Cachexia Sarcopenia and Muscle
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
- (2017) Kidney International Supplements
- Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
- (2016) Stuart M. Sprague et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial
- (2016) Marion Schneider Meireles et al. CLINICAL NUTRITION
- Parathyroid hormone metabolism and signaling in health and chronic kidney disease
- (2016) Pieter Evenepoel et al. KIDNEY INTERNATIONAL
- Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial
- (2015) Kristina Lundwall et al. AMERICAN JOURNAL OF NEPHROLOGY
- Determinants of parathyroid hormone response to vitamin D supplementation: a systematic review and meta-analysis of randomised controlled trials
- (2015) Nazanin Moslehi et al. BRITISH JOURNAL OF NUTRITION
- Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation
- (2015) Martin Petkovich et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease
- (2015) Mehmet Baha Aytaç et al. PEDIATRIC NEPHROLOGY
- Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
- (2015) Stuart M. Sprague et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
- (2015) Eleonora Riccio et al. PLoS One
- A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients
- (2014) Adeera Levin et al. BMC Cardiovascular Disorders
- A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3-4 CKD
- (2014) D. W. Coyne et al. Clinical Journal of the American Society of Nephrology
- Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial
- (2014) Carmine Zoccali et al. HYPERTENSION
- A Predictive Equation to Guide Vitamin D Replacement Dose in Patients
- (2014) G. Singh et al. Journal of the American Board of Family Medicine
- Hypovitaminosis D in a sunny country: Time trends, predictors, and implications for practice guidelines
- (2014) Maha Hoteit et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ergocalciferol and Microcirculatory Function in Chronic Kidney Disease and Concomitant Vitamin D Deficiency: An Exploratory, Double Blind, Randomised Controlled Trial
- (2014) Gavin Dreyer et al. PLoS One
- Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older
- (2013) Elke S. Schaeffner et al. ANNALS OF INTERNAL MEDICINE
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- Cholecalciferol (Vitamin D3) Therapy and Vitamin D Insufficiency in Patients with Chronic Kidney Disease: A Randomized Controlled Pilot Study
- (2013) Prakash Chandra et al. Endocrine Practice
- Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease
- (2013) J A Alvarez et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Paricalcitol on Left Ventricular Mass and Function in CKD--The OPERA Trial
- (2013) A. Y.-M. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management
- (2013) David W Johnson et al. NEPHROLOGY
- Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial
- (2013) Thomas Larsen et al. BMC Nephrology
- High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial
- (2012) Jessica A Alvarez et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Ergocalciferol and Cholecalciferol in CKD
- (2012) Sagar U. Nigwekar et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
- (2012) Ravi Thadhani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Systematic Review: Influence of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentration
- (2012) Philippe Autier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The pleiotropic effects of vitamin D in bone
- (2012) Paul H. Anderson et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Paricalcitol does not improve glucose metabolism in patients with stage 3–4 chronic kidney disease
- (2012) Ian H. de Boer et al. KIDNEY INTERNATIONAL
- Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial
- (2012) William G Petchey et al. NEPHROLOGY
- Paricalcitol Versus Ergocalciferol for Secondary Hyperparathyroidism in CKD Stages 3 and 4: A Randomized Controlled Trial
- (2011) Csaba P. Kovesdy et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A systematic review and meta-regression analysis of the vitamin D intake–serum 25-hydroxyvitamin D relationship to inform European recommendations
- (2011) Kevin D. Cashman et al. BRITISH JOURNAL OF NUTRITION
- Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease
- (2011) R. Hojs et al. CLINICAL NEPHROLOGY
- The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease
- (2011) JoAnn E. Manson et al. Contemporary Clinical Trials
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
- (2011) Michael F. Holick et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin–angiotensin–aldosterone system inhibition
- (2011) Min Jeong Kim et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation
- (2011) Adriana S. Dusso Kidney International Supplements
- A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease
- (2010) S. M. Moe et al. Clinical Journal of the American Society of Nephrology
- Does Blockade of the Renin-Angiotensin-Aldosterone System Slow Progression of All Forms of Kidney Disease?
- (2010) Michael R. Lattanzio et al. CURRENT HYPERTENSION REPORTS
- Vitamin D: Metabolism
- (2010) Sylvia Christakos et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
- (2010) A. Catharine Ross et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reduced Hepatic Synthesis of Calcidiol in Uremia
- (2010) J. Michaud et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Foreword
- (2009) Kai-Uwe Eckardt et al. KIDNEY INTERNATIONAL
- Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
- (2008) Pooneh Alborzi et al. HYPERTENSION
- Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease
- (2008) Adrián Okša et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Calcimimetics in chronic kidney disease: evidence, opportunities and challenges
- (2008) Pieter Evenepoel KIDNEY INTERNATIONAL
- Effect of Depot Oral Cholecalciferol Treatment on Secondary Hyperparathyroidism in Stage 3 and Stage 4 Chronic Kidney Diseases Patients
- (2008) Ekrem Dogan et al. RENAL FAILURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now